to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResi?n Arterial en DIab?ticos tipo Dos) study.
Kidney dysfunction, cardiorespiratory fitness, and the risk of death in women.
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study.
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
Renal denervation and left ventricular mass regression: a benefit beyond blood pressure reduction?
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.